L’ASAQ, une avancée dans la lutte contre le paludisme [ASAQ, an advance in the battle against malaria].

Abstract

This editorial (in French) presents ASAQ, a fixed-dose combination of artesunate and amodiaquine launched in March 2007 by the Drugs for Neglected Diseases initiative (DNDi) and sanofi-aventis. The combination is intended for treating uncomplicated Plasmodium falciparum malaria in malaria-endemic countries in Africa.

Citation

Kiechel, J.R.; Pécoul, B. L’ASAQ, une avancée dans la lutte contre le paludisme [ASAQ, an advance in the battle against malaria]. Medecine Tropicale (2007) 67 (2) 109-110.

  • kiechel_pecoul_med_trop_2007_p109.pdf
  • [109-110-_editorial-pecoul_109-110-editorial-pecoul.pdf](http://www.revuemedecinetropicale.com/109-110-editorial-pecoul_109-110-editorial-_pecoul.pdf)

Help us improve GOV.UK

Don’t include personal or financial information like your National Insurance number or credit card details.